Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    15172900 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism
Intervention: Drug: Fondaparinux
2 Terminated Mortality Due to Malignancy in Patients With Idiopathic Venous Thromboembolism
Conditions: Venous Thromboembolism;   Malignancy
Intervention: Other: screening

Study has passed its completion date and status has not been verified in more than two years.